Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Quest Buying AmeriPath for $1.23 Billion - Medical Product Outsourcing

Quest Buying AmeriPath for $1.23 Billion

Quest Diagnostics Inc. will purchase diagnostic testing company.

Medical testing company Quest Diagnostics Inc. said Monday it will buy diagnostic testing company AmeriPath Inc. for about $1.23 billion in cash.

The $2 billion deal includes about $770 million in debt.

Quest plans to pay for the acquisition, refinance AmeriPath’s existing debt and the debt from the HemoCue acquisition completed earlier this year with the proceeds of a new $1 billion one-year bridge loan and a new five-year $1.5 billion term loan, both committed to be underwritten by Morgan Stanley (nyse: MS – news – people ). The bridge loan is expected to be refinanced shortly after the closing.

“This acquisition will establish our leading position in cancer diagnostics with a focus on dermatopathology, anatomic pathology and molecular diagnostics,” Quest Chairman and Chief Executive Surya N. Mohapatra said in a statement.

AmeriPath is controlled by Welsh, Carson, Anderson and Stowe IX LP.

Quest said the deal should add modestly to 2008 earnings per share, before anticipated charges related to the transaction.

The acquisition is expected to close during the second quarter.

SOURCE: AP

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics